ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

MST Mid-States

1.625
0.00 (0.00%)
02 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Mid-States LSE:MST London Ordinary Share GB0002683034 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.625 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Trading Update

20/01/2010 7:00am

UK Regulatory



 

TIDMMST 
 
RNS Number : 8119F 
Mid-States PLC 
20 January 2010 
 

PRESS RELEASE 
20 January 2010 
 
 
MID-STATES PLC (the "Company") 
Update on current business 
The Board is pleased to announce that in the first half of the financial year 
ended 30 June 2010 the Company has seen continued progress in its air 
disinfection business. The Board believes that the 
 new business strategy 
adopted last year, its strengthened management team and the heightened awareness 
of viral threats (including swine 'flu), through national and international 
press coverage, have been significant factors in this progress. 
 
 
Orders received in the six months ended 31 December 2009 for the Company's AD 
air disinfection device totalled 679. These included larger orders from 
distributors in Spain, the Middle East and Norway 
together with others which 
were predominantly relatively low volume sales to potential new distributors as 
the Company seeks to establish sales channels in new markets, both in the UK and 
internationally. The Company is presently working with or in discussions with 25 
distributors in different market sectors and territories around the world. In 
addition, there are now over 450 AD in use at UK hospitals, successfully and 
demonstrably playing a key role in the ongoing fight against viral and bacterial 
pathogens. 
 
 
Revenue for the first half is expected to be close to GBP0.2 million and at 31 
December 2009 cash at bank 
was GBP0.94 million. 
 
 
The Company expects to publish its Interim Financial Statements for the six 
months ended 31 December 
2009 towards the end of March and 
further information on trading will be provided at this time. 
 
 
 
 
Javier Segura, Managing Director, commented: 
 
 
"Whilst we are only half way through the Company's financial year, which formed 
a period of transition, I am encouraged by progress already achieved. The 
continued strategy of expanding into non-healthcare markets and internationally 
should bring further growth as we progress through the remainder of the 
financial year." 
 
 
 
 
 
 
For further information 
Mid-States PLCTel: +44 (0) 20 7603 1515 
Andrew Tonks, Finance Director 
Panmure Gordon (UK) Limited                             Tel: +44 (0) 20 7459 
3600 
Andrew Godber 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 TSTGGUGAGUPUGMB 
 

1 Year Mid-states Chart

1 Year Mid-states Chart

1 Month Mid-states Chart

1 Month Mid-states Chart

Your Recent History

Delayed Upgrade Clock